mRNA Vaccine Efficacy and Computational Safety Frameworks for Generative AI Reported in Recent Studies

Messenger RNA (mRNA) vaccines combine rapid development timelines, scalable manufacturing capabilities, strong immunogenicity, and a favorable safety profile. During the COVID-19 pandemic, billions of doses were administered globally across diverse populations. A review examining the modification of mRNA-lipid-nanoparticle vaccine components to fine-tune immune responses was published online on June 24, 2026. Generative AI tools include large language models and text-to-image diffusion models. Computational safety is formalized as a mathematical framework using signal processing theory to assess generative AI challenges.